awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35667279-9D5E72E1-E28B-4915-A4A9-358A0E26CD87
Q35667279-9D5E72E1-E28B-4915-A4A9-358A0E26CD87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35667279-9D5E72E1-E28B-4915-A4A9-358A0E26CD87
Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.
P2860
Q35667279-9D5E72E1-E28B-4915-A4A9-358A0E26CD87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35667279-9D5E72E1-E28B-4915-A4A9-358A0E26CD87
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
057dee103796d1e56e1f30d088f337318c2dc9c7
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).